Delivery Order SPE2DB20D3303-SPE2DB26FY2F0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,175.76 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL formulations. The contract is firm fixed price with no set-aside designation and was competitively awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin on June 11, 2025, with a ceiling value of $1,917.75. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of June 12, 2025. This delivery order represents a small-value pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $2,872.47 on September 23, 2025. The order covers Lantus SoloStar 100 Unit/mL insulin in 3mL quantities and will be performed at the contractor's Conshohocken facility with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ML quantities, with a ceiling value of $1,026.67. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a discrete task under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.74 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities. This competitively awarded, firm fixed-price delivery order was issued on October 21, 2025, with an ultimate completion date of October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This $1,022.80 firm fixed-price contract represents a single delivery order with an ultimate completion date of October 24, 2025. The award was not set-aside and was competitively awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities, valued at $1,022.80 with a firm fixed price arrangement. The order, issued on September 26, 2025, has an ultimate completion date of September 29, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award utilized no set-aside designation and was competitively awarded through open competition. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin, with a contract value of $1,888.24 and an ultimate completion date of September 23, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a purchase of pharmaceutical supplies supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL pen format. This is a firm fixed-price contract with a ceiling value of $3,068.40 and an ultimate completion date of September 24, 2025. The contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL vials, with a contract ceiling value of $8,649.77. The award was made on August 6, 2025, with an ultimate completion date of August 7, 2025, under a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2F0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,091.16 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin on November 5, 2025, with completion expected by November 6, 2025. This firm fixed-price, non-set-aside contract is being performed at the company's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical procurement supporting federal medical supply needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The parent contract functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The IDC represents a critical sourcing mechanism that allows the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems to efficiently procure pharmaceutical products through a flexible contracting vehicle designed to support defense medical logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/5/25 |